The reasons for this discrepancy might be significant methodological heterogeneities across studies, including variations in patient populations (e.g. disease stage, comorbidities) and differences in therapeutic interventions, compound these biological variances, ultimately leading to divergent findings in the studies.
← all excerpts
The role of neutrophils, red blood cells, and platelets in the pathology of Alzheimer's disease.
1
—
—